TABLE OF CONTENTS LIST OF TABLES ...............................................................................................
![Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells | Molecular Pharmaceutics Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.2c00033/asset/images/medium/mp2c00033_0003.gif)
Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells | Molecular Pharmaceutics
![A Route to Lipid ALC‐0315: a Key Component of a COVID‐19 mRNA Vaccine - Saadati - 2022 - Chemistry – A European Journal - Wiley Online Library A Route to Lipid ALC‐0315: a Key Component of a COVID‐19 mRNA Vaccine - Saadati - 2022 - Chemistry – A European Journal - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/bfb67bc0-2a2f-4912-ad43-5c8fa032ef8e/chem202200906-toc-0001-m.jpg)
A Route to Lipid ALC‐0315: a Key Component of a COVID‐19 mRNA Vaccine - Saadati - 2022 - Chemistry – A European Journal - Wiley Online Library
![Structure and pKa value of DLin-MC3-DMA (A), SM-102 (B), and Alc-0315... | Download Scientific Diagram Structure and pKa value of DLin-MC3-DMA (A), SM-102 (B), and Alc-0315... | Download Scientific Diagram](https://www.researchgate.net/publication/359373811/figure/fig1/AS:1139009728331779@1648572489767/Structure-and-pKa-value-of-DLin-MC3-DMA-A-SM-102-B-and-Alc-0315-C-Copyright-is_Q320.jpg)
Structure and pKa value of DLin-MC3-DMA (A), SM-102 (B), and Alc-0315... | Download Scientific Diagram
![Molecules | Free Full-Text | Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy Molecules | Free Full-Text | Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy](https://pub.mdpi-res.com/molecules/molecules-27-01943/article_deploy/html/images/molecules-27-01943-g004.png?1647512236)
Molecules | Free Full-Text | Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy
![4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate [DHA] [ALC -0315] CAS: 2036272-55-4 Manufacturer | Sinopeg.com 4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate [DHA] [ALC -0315] CAS: 2036272-55-4 Manufacturer | Sinopeg.com](https://www.sinopeg.com/uploadfile/202102/01/d56d2208b7cc43cd5c065d0fa5d039e5_medium.jpg)